-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pharmaceutical network September 27th, a large number of enterprises won the bid, involving the crown pulse intervention balloon, orthopaedic hip joint, the end of the article attached 180 pages of complete catalog, free one-click access to arms enterprises to take 2 years of supply rights September 25, Zhejiang Province pharmaceutical procurement platform released "Zhejiang Province public medical institutions part of the medical supplies with the volume of procurement results announced", according to the Zhejiang Provincial Medical Security Bureau previously issued the volume of procurement work program, after registration, quotation, evaluation and other links.
this product range is coronary intervention balloon, orthopaedic hip 2 types of medical supplies.
the scope of medical institutions is all public medical institutions in the province have other special hospitals, procurement cycle of 2 years.
Public medical institutions and the winning enterprises shall sign a supply agreement through the provincial pharmaceutical procurement platform, give priority to the purchase of the winning product at the winning price, and shall not enter into other agreements that deviate from the substantive contents of the terms of the supply agreement.
period, if the medical institution completes the agreed purchase quantity in advance, the winning enterprise shall continue to supply according to the winning price until the end of the agreement.
in terms of distribution supply.
the winning enterprise is the first responsible person to ensure product quality and supply, the winning enterprise can self-distribute, can also entrust distribution, and set up emergency reserves, inventory and stop-production reporting system.
to entrust distribution, a certain number of distribution enterprises shall be selected in accordance with the principle of mutual voluntary in the list of qualified distribution enterprises of the provincial pharmaceutical procurement platform.
the situation of non-supply according to the agreement, can not guarantee quality or supply, etc. , will be handled in accordance with the relevant provisions.
must be the lowest procurement price in the history of the country the lowest procurement price in the history of the country is very special in the program.
The lowest purchase price in the history of our country refers to the lowest value in the purchase price of medical institutions in our province, and the winning bid price (hanging net price, with volume purchase price) of centralized procurement in other provinces (regions and cities) in the province, which shall be filled in online by the bidding enterprises themselves.
The bidding enterprise shall truthfully fill in the report, and if it finds that there is a false national historical minimum purchase price, reject the tender for the product; if there are 3 or more products in the same secondary catalogue group with the lowest purchase price in the history of the country, it shall reject all the products of the enterprise in the second-level catalogue group.
on the reference price.
second-level catalog group reference price according to the national history of such products the lowest procurement price after expert demonstration determined, before the commercial bid evaluation to inform the bidding enterprises.
the winning bid, the winning quota in the second-level catalogue group is determined by experts according to the clinical use needs of our province, and the bidding enterprises are informed before the commercial bid evaluation.
in terms of agreed procurement volume, the agreed purchase volume is determined by 80% of the transaction volume of public medical institutions in the province in 2019.
medical institutions, as the first responsible person for the settlement of the purchase price, shall settle with the enterprise in a timely manner through the provincial pharmaceutical procurement platform in accordance with the provisions of the agreement, and the return time shall, in principle, be within 90 days from the date of delivery and acceptance of the goods.
the winning bid are: Jermain, Johnson and Johnson, Belang, Stryker, Medtron, Poco and so on.
the full directory is long, for easy viewing, please sweep the following QR code, reply 123 can be obtained free of charge with one click.
following are excerpts from the winning bid results of some enterprises: